Stocks fell in the afternoon session due to concerns over worsening trade relations with China following critical comments from President Trump. The trade dispute intensified after China imposed export controls on rare earth minerals, causing worries about supply chain disruptions and increased costs for tech companies. Among the impacted stocks was Globus Medical, which saw a decline following the unexpected resignation of its President and CEO. The company reaffirmed its 2025 guidance but the sudden change introduced uncertainty. Globus Medical is down 30.6% this year, trading 39.1% below its 52-week high. Investors should consider the impact of generative AI on large corporations.

Read more at StockStory.: Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know